mini VIDAS®

GUDID 03573026140441

The mini VIDAS is a complete standalone immunodiagnostic system using VIDAS assay kits.

BIOMERIEUX SA

Fluorescent immunoassay analyser IVD, laboratory
Primary Device ID03573026140441
NIH Device Record Key12356643-f674-4bd3-bd28-72beaeb9afc2
Commercial Distribution StatusIn Commercial Distribution
Brand Namemini VIDAS®
Version Model Number99737
Company DUNS276816717
Company NameBIOMERIEUX SA
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datefalse
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween -10 Degrees Celsius and 40 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS103573026140441 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

JJEAnalyzer, Chemistry (Photometric, Discrete), For Clinical Use

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number4
Public Version Date2023-01-12
Device Publish Date2016-09-14

Devices Manufactured by BIOMERIEUX SA

03573026359096 - VITEK® MS-DS2024-04-30 The VITEK MS-DS target slides enable the identification of microorganisms according to the MALDI-TOF mass spectrometry method.
03573026359119 - VITEK® MS2024-04-29 MALDI-Tof Mass Spectrometry system used for microbial identification
03573026362843 - VITEK® MS FA2024-04-29 VITEK ® MS - FA is used to pretreat yeasts to facilitate their identification according to the MALDI - TOF method. It is used e
03573026619527 - VIDAS® PC SOFTWARE V4.92024-04-29 VIDAS PC V4.9 W10 Software version for clinic
03573026256685 - ETEST® Gentamicin (GM)2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
03573026376604 - ETEST® Amoxicillin (AC)2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
03573026377731 - ETEST® Flucytosine (FC)2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions
03573026560690 - ETEST® Meropenem/Vaborbactam (MEV)2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.